These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus. Rosa CM; Gimenes R; Campos DH; Guirado GN; Gimenes C; Fernandes AA; Cicogna AC; Queiroz RM; Falcão-Pires I; Miranda-Silva D; Rodrigues P; Laurindo FR; Fernandes DC; Correa CR; Okoshi MP; Okoshi K Cardiovasc Diabetol; 2016 Sep; 15(1):126. PubMed ID: 27585437 [TBL] [Abstract][Full Text] [Related]
8. Long-term use of low-dose spironolactone in spontaneously hypertensive rats: effects on left ventricular hypertrophy and stiffness. Baldo MP; Forechi L; Morra EA; Zaniqueli D; Machado RC; Lunz W; Rodrigues SL; Mill JG Pharmacol Rep; 2011; 63(4):975-82. PubMed ID: 22001985 [TBL] [Abstract][Full Text] [Related]
9. Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats. Tanabe A; Naruse M; Hara Y; Sato A; Tsuchiya K; Nishikawa T; Imaki T; Takano K J Hypertens; 2004 May; 22(5):1017-23. PubMed ID: 15097243 [TBL] [Abstract][Full Text] [Related]
10. Eplerenone offsets cardiac and aortic adverse remodeling in spontaneously hypertensive rats. Burla AK; Neves MF; Oigman W; Mandarim-de-Lacerda CA Int J Cardiol; 2007 Jan; 114(1):64-70. PubMed ID: 16650491 [TBL] [Abstract][Full Text] [Related]
11. Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR. Susic D; Varagic J; Ahn J; Matavelli L; Frohlich ED Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H175-9. PubMed ID: 16905598 [TBL] [Abstract][Full Text] [Related]
12. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery. Tsukashita M; Marui A; Nishina T; Yoshikawa E; Kanemitsu H; Wang J; Ikeda T; Komeda M J Thorac Cardiovasc Surg; 2008 Jul; 136(1):58-64. PubMed ID: 18603054 [TBL] [Abstract][Full Text] [Related]
13. Blood pressure variability activates cardiac mineralocorticoid receptor and induces cardiac remodeling in hypertensive rats. Yasuoka S; Kai H; Kajimoto H; Kudo H; Takayama N; Anegawa T; Koga M; Miyamoto T; Mifune H; Kage M; Hirooka Y; Imaizumi T Circ J; 2013; 77(6):1474-81. PubMed ID: 23470864 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway. Chen Y; Chang Y; Zhang N; Guo X; Sun G; Sun Y Cell Physiol Biochem; 2018; 46(3):1009-1018. PubMed ID: 29669326 [TBL] [Abstract][Full Text] [Related]
15. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Boluyt MO; Bing OH; Lakatta EG Eur Heart J; 1995 Dec; 16 Suppl N():19-30. PubMed ID: 8682057 [TBL] [Abstract][Full Text] [Related]
16. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone. López-Andrés N; Martin-Fernandez B; Rossignol P; Zannad F; Lahera V; Fortuno MA; Cachofeiro V; Díez J Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338 [TBL] [Abstract][Full Text] [Related]
17. Effects of spironolactone in spontaneously hypertensive adult rats subjected to high salt intake. Baldo MP; Zaniqueli D; Forechi L; Machado RC; Rodrigues SL; Mill JG Clinics (Sao Paulo); 2011; 66(3):477-82. PubMed ID: 21552676 [TBL] [Abstract][Full Text] [Related]
18. Impact of aldosterone receptor blockade on the deleterious cardiac effects of adrenergic activation in hypertensive rats. Veliotes DG; Norton GR; Correia RJ; Strijdom H; Badenhorst D; Brooksbank R; Woodiwiss AJ J Cardiovasc Pharmacol; 2010 Aug; 56(2):203-11. PubMed ID: 20531215 [TBL] [Abstract][Full Text] [Related]
19. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755 [TBL] [Abstract][Full Text] [Related]
20. Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure. Kambara A; Holycross BJ; Wung P; Schanbacher B; Ghosh S; McCune SA; Bauer JA; Kwiatkowski P J Cardiovasc Pharmacol; 2003 Jun; 41(6):830-7. PubMed ID: 12775959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]